Treatment of CNS Tumors in Childhood Slows Academic Readiness
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 28, 2024 -- Treatment of central nervous system (CNS) tumors in early childhood is associated with slowed development of academic readiness, which predicts distal academic outcomes in reading and math, according to a study published online Aug. 20 in the Journal of the National Cancer Institute.
Melanie R. Somekh, Ph.D., from St. Jude Children's Research Hospital in Memphis, Tennessee, and colleagues examined academic readiness among 70 patients with newly diagnosed CNS tumors during early childhood in a prospective, longitudinal, multisite study. Patients were treated with chemotherapy, with or without photon or proton irradiation.
The researchers found that over time, mixed linear models revealed slowed development of academic readiness skills. At all time points, socioeconomic status was predictive of academic readiness. Compared with normative expectations, distal reading difficulties were proportionally greater, while there was no difference in math difficulties. Distal academic outcomes in reading and math were predicted by academic readiness.
"Findings regarding increased risk for slowed development of academic skills may inform caregiver education and provide meaningful insights for clinicians speaking with families about possible impacts of CNS tumor diagnosis and treatment on academic functioning amongst our youngest patients," the authors write. "Further, they highlight the need for close monitoring of academic readiness and the potential importance of implementing interventions targeting early academic skills in this population."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Overdiagnosis of Thyroid Cancer Persists
WEDNESDAY, Feb. 12, 2025 -- Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb. 5 in The Lancet Diabetes...
In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition
WEDNESDAY, Feb. 12, 2025 -- Post-COVID condition (PCC) continues to affect children, and 80 percent of those currently experiencing PCC have activity limitation, according to a...
Performance of AI Preeclampsia Prediction Models Deteriorates Over Time
WEDNESDAY, Feb. 12, 2025 -- For the Preeclampsia Integrated Estimate of RiSk (PIERS) Machine Learning (PIERS-ML) model and the logistic regression-based fullPIERS model...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.